W. R. Berkley Corporation to Present at the 2024 UBS Financial Services Conference
W. R. Berkley Corporation to Present at the 2024 UBS Financial Services Conference
W. R. Berkley Corporation (NYSE: WRB) announced today that W. Robert Berkley, Jr., its president and chief executive officer, will present at the UBS 2024 Financial Services Conference in Key Biscayne, Miami, FL. The presentation will take place on Monday, February 26, 2024 at 10:30 a.m. eastern time.
The presentation will be webcast live on the Company’s website at www.berkley.com. Please log on early to register. A replay of the webcast will be available on the Company’s website within 24 hours and remain accessible for approximately 90 days.
Founded in 1967, W. R. Berkley Corporation is an insurance holding company that is among the largest commercial lines writers in the United States and operates worldwide in two segments of the property casualty insurance business: Insurance and Reinsurance & Monoline Excess.
For further information about W. R. Berkley Corporation, please visit www.berkley.com.
Karen A. Horvath
Vice President – External
Financial Communications
203-629-3000
View source version on businesswire.com: https://www.businesswire.com/news/home/20240220038192/en/
-
5 Undervalued Stocks to Buy to Play a Little Defense
-
Markets Brief: AI Leaders Excel In Earnings Season So Far
-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
Going Into Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?
-
What’s the Difference Between the CPI and PCE Indexes?
-
After Earnings, Is Tesla Stock a Buy, a Sell, or Fairly Valued?
-
After Earnings, Is GE Aerospace Stock a Buy, a Sell, or Fairly Valued?
-
3 Good Stocks to Buy with Your Tax Refund in 2024 (Or with Any Extra Money)
-
SoFi Earnings: Revenue Growth Slows on Lower Loan Growth and Higher Credit Costs
-
Tesla: Full Self-Driving Approval In China Supports Our View for Deliveries Growth In 2024
-
Philips Earnings: Firm Reaches $1.1 Billion Settlement Agreement
-
AbbVie Earnings: Next-Generation Immunology Drugs Help Offset Humira Biosimilar Pressure
-
Exxon Earnings: Ignore Earnings Shortfall as Long-Term Growth and Improvement on Track